Navigation Links
JCI online early table of contents: Dec. 1, 2010
Date:12/1/2010

e mice, leading the authors to look at this in human Wilms tumor. As increased ERK1/2 activity was also observed in some human Wilms tumors, the authors suggest that their new mouse model of Wilms tumor will provide a useful tool to study the initiation and progression of Wilms tumor and to investigate potential new therapeutic strategies.

TITLE: Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

AUTHOR CONTACT:
Vicki Huff
University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Phone: 713.834.6384; Fax: 713.834.6380; E-mail: vhuff@mdacc.tmc.edu.

View this article at: http://www.jci.org/articles/view/43772?key=327424cb3e5048c4b90e


ENDOCRINOLOGY: Hormone deficiency is the pits

The pituitary is a gland at the base of the brain that produces a number of hormones that regulate growth, reproduction, and metabolism. PIT-1 is a gene that controls the expression of many of those hormones, including growth hormone (GH), prolactin (PRL), and thyroid-stimulating hormone (TSH). Human mutations in PIT-1 are linked to short stature and multiple hormone deficiency. In new research, Yukaka Takahashi and colleagues at Kobe University Graduate School of Medicine in Kobe, Japan, investigated several patients who exhibited normal growth but adult-onset deficiency of GH, PRL, and TSH. They found that although these patients did not have mutations in PIT-1, each had PIT-1specific antibodies in their blood. The researchers believe that these patients suffer from a unique autoimmune disorder that results in the immune system attacking PIT-1expressing cells in the pituitary.

TITLE: Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans

AUTHOR CONTACT:
Yutaka Takahas
'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. TheReliefPlace.com Launches Online Store “The Relief Shop” - What Does this Medical Supply Store Carry and How Can They Help You?
2. Web Content Management Enables Government Transparency, Participation, and Collaboration Online
3. DavisPTnetwork Partners with the New York Physical Therapy Association to Provide Online Continuing Education
4. PERSONALABS Offers Discounted Healthy Heart Online Blood Tests in February
5. Pharmahelper Pleased To Recognize Online Pharmacy Practice Standards Announced By Google Adwords
6. Online Dating Reinvents Itself with the Recent Roll-Out of Teacherhookup.com, a Free Website that Focuses on a Person's Career in Education!
7. EdenHome.com Adds Aventura Organic Clothes to Site and Announces Largest Online Selection of Stylish Organic Clothes for Men, Women and Children
8. Fire Protection Online Resolves Safety Concerns with CO2 Fire Extinguishers
9. JCI online early table of contents: Feb. 15, 2010
10. Fitness Trend Towards Online Personal Training Gets Real-World Weight Loss Results on FitOrbit.com
11. New Online Store Makes Buying Cosmetics a Healthy Choice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... September 01, 2015 , ... The PT Outcomes Registry is an ... for physical therapy patients. The Registry is being developed by the American Physical Therapy ... are happy to be selected to contribute FOTO Outcomes measures as one of the ...
(Date:8/31/2015)... ... August 31, 2015 , ... ITC Global Translations website, ... for specific translation services within the medical and pharmaceutical industries. These are industries ... successful work. , ITC Global Translations specializes in professional translation services for materials ...
(Date:8/31/2015)... ... August 31, 2015 , ... India Network Foundation, ... InstantQuote ” tool, which summarizes all available plans, plan maximums, pre-existing condition coverage ... designed to help India Network members make an informed decision regarding the care ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... postnatal fitness classes. , Starting September 1st they are offering pre ... Mom Bod" and "Healthy Body, Healthy Baby." , More information can be found ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Sundance Film Festival award winning ... 1. , “Alive Inside” shadows a social worker who advocates for the use of ... documentary about bringing music to residents in health care centers who may have lost ...
Breaking Medicine News(10 mins):Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2
... , ASHEVILLE, N.C. , Jan. ... and smart companies are working hard to adjust their recipes to find ... is one option that is all natural, low in sodium—40% to 70% ... the first and only natural low sodium sea salt. Total sales that ...
... , St. Jude Children,s Research Hospital scientists lead effort ... host of bacterial toxins , MEMPHIS, Tenn. , ... of widely used cholesterol-lowering drugs might help protect individuals from ... pose a deadly threat to those with sickle cell disease. ...
... Acknowledging that the idea of rationing health care, particularly at ... get much rational consideration, a Johns Hopkins emeritus professor of ... an opinion piece featured in this month,s issue of the ... article, John Freeman, M.D., Lederer Professor Emeritus of Pediatric Neurology ...
... from forming, research shows , TUESDAY, Jan. 19 (HealthDay News) ... tobacco known as NNK contributes to the formation of lung ... Taiwan report that NNK contributes to the accumulation of a ... DNMT1 turns off genes that keep tumors from forming. ...
... chromosome lineage reveals farming influence , TUESDAY, Jan. 19 (HealthDay ... farmers who migrated from the Near East 10,000 years ago, ... Y chromosome, which is passed from father to son. , ... by about 110 million men -- it follows a gradient ...
... ... ALS (amyotrophic laterals sclerosis) announced today that it has appointed Gordon S. LaVigne as ... ... ALS Association , the nation’s leader in the fight against the disease ALS ...
Cached Medicine News:Health News:Ocean's Flavor Natural Sea Salt is Helping Companies Reach Low Sodium Goals 2Health News:Ocean's Flavor Natural Sea Salt is Helping Companies Reach Low Sodium Goals 3Health News:Cholesterol-Lowering Drug Shows Promise Against Serious Infections in Sickle Cell Disease 2Health News:Cholesterol-Lowering Drug Shows Promise Against Serious Infections in Sickle Cell Disease 3Health News:Cholesterol-Lowering Drug Shows Promise Against Serious Infections in Sickle Cell Disease 4Health News:Cholesterol-Lowering Drug Shows Promise Against Serious Infections in Sickle Cell Disease 5Health News:Reasoning through the rationing of end-of-life care 2Health News:Gordon S. LaVigne Appointed ALS Association Chief Development and Communications Officer , 2Health News:Gordon S. LaVigne Appointed ALS Association Chief Development and Communications Officer , 3
(Date:8/31/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... of regenerative medicine, today announced that the third ... -based Rush University Medical Center in a ... doses of AST-OPC1 (oligodendrocyte progenitor cells) in newly ... spinal cord injury (SCI). This represents the final ...
(Date:8/31/2015)... N.J. and STAMFORD, Conn. ... pharmaceutical subsidiary of Eisai Co., Ltd., and Purdue Pharma ... worldwide collaboration agreement for the development and commercialization of ... orexin receptor antagonist entering Phase III clinical development for ... terms of the agreement, Eisai and Purdue Pharma will ...
(Date:8/31/2015)... , Aug. 31, 2015 Bionomics Limited ... and development of innovative therapeutics for the treatment of ... today announced that its BNC101 IND submission has passed ... Bionomics plans to initiate a Phase 1 clinical trial ... with metastatic pancreatic cancer prior to 31 December 2015. ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4
... multiple sclerosis, remained relapse-free after three years of treatment ... active brain lesions - the ... - MS, a devastating disease causing progressive disability, affects 2.5 ... including many young adults - FTY720 regulatory filings planned before ...
... basis of methotrexate,resistance and differences in methotrexate response, ... analysis,of the genetic determinants of resistance to the ... could offer a,pathway to predicting such resistance and ... Children,s Research Hospital study., Besides its use ...
Cached Medicine Technology:FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 2FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 3FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 4FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 5FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 6St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia 2St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia 3St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia 4
The Atria 6100 delivers the highest level of clinical performance while incorporating cutting-edge technology to streamline clinic workflow. It offers timely, high-quality, and accurate ECG results c...
The CSV-1000ETDRS10% test face presents the standard ETDRS test at a contrast level of 10%. This test is widely used in clinical studies for the evaluation of refractive surgery and contact lenses....
The CSV-1000SLanC test face provides the same tests as the standard CSV-1000S, except that the acuity test is presented in Landolt C format. , ,This test is very useful when testing patients who cann...
... CSV-1000E contrast sensitivity chart test face is the ... world. This test provides for four (4) rows ... of 8 ft (2.5 meters), these gratings test ... 18 cycles/degree. The CSV-1000E provides a full contrast ...
Medicine Products: